These constraints of the BTNX NTS are remarkably suitable, as we identified e.g. etodesnitazene to acquire a similar in vitro potency and efficacy as fentanyl [seven, thirteen] and as it could perhaps give PWUD a Bogus perception of safety. Additionally, the detectability of nitazene analogues in drug samples could be impacted by solubility difficu